These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11959614)

  • 1. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemifloxacin is effective in experimental pneumococcal meningitis.
    Smirnov A; Wellmer A; Gerber J; Maier K; Henne S; Nau R
    Antimicrob Agents Chemother; 2000 Mar; 44(3):767-70. PubMed ID: 10681354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
    Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
    García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
    Morrissey I; George JT
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():107-10. PubMed ID: 10824041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics to combat resistance.
    Woodnutt G
    J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():25-31. PubMed ID: 10997596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
    Klugman KP; Gootz TD
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
    Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.